Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Instagram Outage Disrupts Thousands of U.S. Users 
SACRAMENTO, Calif., May 19, 2016 -- The Orange County Register published an opinion piece today by Bridget Hood, a lupus survivor and Lupus L.A. board member and support group facilitator. May is Lupus Awareness Month, dedicated to raising awareness and promoting medical innovation to find treatments or a cure for this debilitating autoimmune disease. Hood has been a continued voice for medical innovation and research.
In the opinion piece, "A time to recommit to the fight against lupus," Hood makes the case that policy makers must do everything in their power to create policies that protect patients and ensure these life-saving medications are available to all who need them.
"The right kinds of public policy can offer hope for those of us who are fighting for new treatments and a cure. Policy makers in Sacramento and Washington D.C. play an important role in helping patients continue their fight. It is vital that we continue to move forward with medical innovation, and not make any kind of policy decisions that would intentionally or unintentionally slow that progress down."
View the full column at The Orange County Register: http://www.ocregister.com/articles/lupus-716357-patients-disease.html
Learn more about the value of medical innovation at www.CALifeSciences.org/Innovation.
|
|||||
About California Life Sciences Association (CLSA)
California Life Sciences Association (CLSA) is the leading voice driving innovation for California's life sciences sector. CLSA works closely with industry, government, academia and other stakeholders to shape public policy, drive business solutions and grow California's life sciences innovation ecosystem. CLSA serves over 750 biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors and service providers. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged to create the state's most influential life sciences advocacy and business leadership organization. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.
Media Contact:
Will Zasadny
Associate Director, Communications
[email protected]
CONTACT: Will Zasadny
Associate Director, Communications
[email protected]
